The Commonwealth Scientific and Industrial Research Organisation (CSIRO) has received a license to work with local Australian biomedical companies to “extract, synthesise, improve and then develop manufacturing processes” for up to 15 different psychedelic compounds.
The organisation will first be collaborating with Melbourne Natural MedTech which is “working to develop psychedelic treatments for several unmet neurological disorders,” said Natural MedTech CEO Mark Hestermann.
